212 related articles for article (PubMed ID: 21376063)
1. Synergistic interactions between PDE4B and GSK-3: DISC1 mutant mice.
Lipina TV; Wang M; Liu F; Roder JC
Neuropharmacology; 2012 Mar; 62(3):1252-62. PubMed ID: 21376063
[TBL] [Abstract][Full Text] [Related]
2. Genetic and pharmacological evidence for schizophrenia-related Disc1 interaction with GSK-3.
Lipina TV; Kaidanovich-Beilin O; Patel S; Wang M; Clapcote SJ; Liu F; Woodgett JR; Roder JC
Synapse; 2011 Mar; 65(3):234-48. PubMed ID: 20687111
[TBL] [Abstract][Full Text] [Related]
3. Behavioral phenotypes of Disc1 missense mutations in mice.
Clapcote SJ; Lipina TV; Millar JK; Mackie S; Christie S; Ogawa F; Lerch JP; Trimble K; Uchiyama M; Sakuraba Y; Kaneda H; Shiroishi T; Houslay MD; Henkelman RM; Sled JG; Gondo Y; Porteous DJ; Roder JC
Neuron; 2007 May; 54(3):387-402. PubMed ID: 17481393
[TBL] [Abstract][Full Text] [Related]
4. Dual inhibitor of PDE7 and GSK-3-VP1.15 acts as antipsychotic and cognitive enhancer in C57BL/6J mice.
Lipina TV; Palomo V; Gil C; Martinez A; Roder JC
Neuropharmacology; 2013 Jan; 64():205-14. PubMed ID: 22749842
[TBL] [Abstract][Full Text] [Related]
5. Social defeat interacts with Disc1 mutations in the mouse to affect behavior.
Haque FN; Lipina TV; Roder JC; Wong AH
Behav Brain Res; 2012 Aug; 233(2):337-44. PubMed ID: 22659396
[TBL] [Abstract][Full Text] [Related]
6. [
Ooms M; Tsujikawa T; Lohith TG; Mabins SN; Zoghbi SS; Sumitomo A; Jaaro-Peled H; Kimura Y; Telu S; Pike VW; Tomoda T; Innis RB; Sawa A; Fujita M
J Cereb Blood Flow Metab; 2019 Jul; 39(7):1306-1313. PubMed ID: 29430995
[TBL] [Abstract][Full Text] [Related]
7. Disrupted in schizophrenia 1 and phosphodiesterase 4B: towards an understanding of psychiatric illness.
Millar JK; Mackie S; Clapcote SJ; Murdoch H; Pickard BS; Christie S; Muir WJ; Blackwood DH; Roder JC; Houslay MD; Porteous DJ
J Physiol; 2007 Oct; 584(Pt 2):401-5. PubMed ID: 17823207
[TBL] [Abstract][Full Text] [Related]
8. Genetic inactivation of GSK3α rescues spine deficits in Disc1-L100P mutant mice.
Lee FH; Kaidanovich-Beilin O; Roder JC; Woodgett JR; Wong AH
Schizophr Res; 2011 Jun; 129(1):74-9. PubMed ID: 21498050
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive behavioral analysis of ENU-induced Disc1-Q31L and -L100P mutant mice.
Shoji H; Toyama K; Takamiya Y; Wakana S; Gondo Y; Miyakawa T
BMC Res Notes; 2012 Feb; 5():108. PubMed ID: 22348257
[TBL] [Abstract][Full Text] [Related]
10. PDE4B5, a novel, super-short, brain-specific cAMP phosphodiesterase-4 variant whose isoform-specifying N-terminal region is identical to that of cAMP phosphodiesterase-4D6 (PDE4D6).
Cheung YF; Kan Z; Garrett-Engele P; Gall I; Murdoch H; Baillie GS; Camargo LM; Johnson JM; Houslay MD; Castle JC
J Pharmacol Exp Ther; 2007 Aug; 322(2):600-9. PubMed ID: 17519386
[TBL] [Abstract][Full Text] [Related]
11. Effects of background mutations and single nucleotide polymorphisms (SNPs) on the Disc1 L100P behavioral phenotype associated with schizophrenia in mice.
Arime Y; Fukumura R; Miura I; Mekada K; Yoshiki A; Wakana S; Gondo Y; Akiyama K
Behav Brain Funct; 2014 Dec; 10():45. PubMed ID: 25487992
[TBL] [Abstract][Full Text] [Related]
12. Specific Inhibition of Phosphodiesterase-4B Results in Anxiolysis and Facilitates Memory Acquisition.
McGirr A; Lipina TV; Mun HS; Georgiou J; Al-Amri AH; Ng E; Zhai D; Elliott C; Cameron RT; Mullins JG; Liu F; Baillie GS; Clapcote SJ; Roder JC
Neuropsychopharmacology; 2016 Mar; 41(4):1080-92. PubMed ID: 26272049
[TBL] [Abstract][Full Text] [Related]
13. Dissecting DISC1 function through protein-protein interactions.
Brandon NJ
Biochem Soc Trans; 2007 Nov; 35(Pt 5):1283-6. PubMed ID: 17956330
[TBL] [Abstract][Full Text] [Related]
14. Disrupted-in-schizophrenia-1 Gln31Leu polymorphism results in social anhedonia associated with monoaminergic imbalance and reduction of CREB and β-arrestin-1,2 in the nucleus accumbens in a mouse model of depression.
Lipina TV; Fletcher PJ; Lee FH; Wong AH; Roder JC
Neuropsychopharmacology; 2013 Feb; 38(3):423-36. PubMed ID: 23011268
[TBL] [Abstract][Full Text] [Related]
15. Isoform-selective susceptibility of DISC1/phosphodiesterase-4 complexes to dissociation by elevated intracellular cAMP levels.
Murdoch H; Mackie S; Collins DM; Hill EV; Bolger GB; Klussmann E; Porteous DJ; Millar JK; Houslay MD
J Neurosci; 2007 Aug; 27(35):9513-24. PubMed ID: 17728464
[TBL] [Abstract][Full Text] [Related]
16. Interactions of human truncated DISC1 proteins: implications for schizophrenia.
Newburn EN; Hyde TM; Ye T; Morita Y; Weinberger DR; Kleinman JE; Lipska BK
Transl Psychiatry; 2011 Aug; 1(8):e30. PubMed ID: 22832604
[TBL] [Abstract][Full Text] [Related]
17. Dysregulation of hepatic cAMP levels via altered Pde4b expression plays a critical role in alcohol-induced steatosis.
Avila DV; Barker DF; Zhang J; McClain CJ; Barve S; Gobejishvili L
J Pathol; 2016 Sep; 240(1):96-107. PubMed ID: 27287961
[TBL] [Abstract][Full Text] [Related]
18. Phosphodiesterase 4 inhibition enhances the dopamine D1 receptor/PKA/DARPP-32 signaling cascade in frontal cortex.
Kuroiwa M; Snyder GL; Shuto T; Fukuda A; Yanagawa Y; Benavides DR; Nairn AC; Bibb JA; Greengard P; Nishi A
Psychopharmacology (Berl); 2012 Feb; 219(4):1065-79. PubMed ID: 21833500
[TBL] [Abstract][Full Text] [Related]
19. Venlafaxine increases cell proliferation and regulates DISC1, PDE4B and NMDA receptor 2B expression in the hippocampus in chronic mild stress mice.
Zhang X; Li X; Li M; Ren J; Yun K; An Y; Lin L; Zhang H
Eur J Pharmacol; 2015 May; 755():58-65. PubMed ID: 25769842
[TBL] [Abstract][Full Text] [Related]
20. Antipsychotic profile of rolipram: efficacy in rats and reduced sensitivity in mice deficient in the phosphodiesterase-4B (PDE4B) enzyme.
Siuciak JA; Chapin DS; McCarthy SA; Martin AN
Psychopharmacology (Berl); 2007 Jun; 192(3):415-24. PubMed ID: 17333137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
